Inicio/Acciones/MCRB

MCRB

USD

Seres Therapeutics Inc. Common Stock

$13.750-1.380 (-9.121%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$15.130

Máximo

$15.340

Mínimo

$13.750

Volumen

0.08M

Fundamentos de la Empresa

Capitalización de Mercado

120.4M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.16M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $6.53Actual $13.750Máximo $24.665

Noticias Relacionadas

29 oct 2025 · 11:00

GlobeNewswire

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

CAMBRIDGE, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading live biotherapeutics company, today announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

14 oct 2025 · 11:00

GlobeNewswire

Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant

CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that new post hoc data from its SER-155 Phase